Jain Global’s Beam Therapeutics BEAM Stock Holding History

Jain Global’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-19,432	Closed	-$482K	–	1078
2024 Q4	$482K	Buy	+19,432	New	+$496K	0.01%	450

Other funds holding BEAM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jain Global's BEAM Position: Q1 2025 in Review

Jain Global sold out of Beam Therapeutics (BEAM) in Q1 2025, closing a stake of 19,432 shares — an estimated $482K sold.

Jain Global first reported a position in BEAM in Q4 2024 and held it in 1 quarter. The position peaked at $482K in Q4 2024. 238 funds tracked by Wall St. Rank hold BEAM as of Q1 2025.

Jain Global reported no remaining Beam Therapeutics position as of Q1 2025 after selling out during the quarter.
Jain Global sold 19,432 Beam Therapeutics shares in Q1 2025, an estimated $482K.
Jain Global first reported a position in Beam Therapeutics in Q4 2024 and held it in 1 quarter.
Jain Global's Beam Therapeutics position peaked at $482K in Q4 2024.
238 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2025.

Based on Jain Global's 13F filing for Q1 2025, filed 15 May 2025.